Mateo M. Salgado

Dr. Mateo M. Salgado

UBU
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2021 in Molecules
Verified
Journal Article
Open access
PDF file
MSMateo M. Salgado
Mateo M. Salgado
AMAlejandro Manchado
Alejandro Manchado
CNCarlos T Nieto
Carlos T Nieto
David DiezDavid Diez
David Diez
NGNarciso M. Garrido
Narciso M. Garrido
Ezetimibe is a well-known drug that lowers blood cholesterol levels by reducing its absorption in the small intestine when joining to Niemann-Pick C1-like protein (NPC1L1). A ligand-based study on ezetimibe analogues is reported, together with one-hit synthesis, highlighted in the study. A convenient asymmetric synthesis of (2S,3S)-N-α-(R)-methylbenzyl-3-methoxycarbonylethyl-4-methoxyphenyl β-lactam is described starting from Baylis–Hillman adducts. The route involves a domino process: allylic acetate rearrangement, stereoselective Ireland–Claisen rearrangement and asymmetric Michael addition, which provides a δ-amino acid derivative with full stereochemical control. A subsequent inversion of ester and acid functionality paves the way to the lactam core after monodebenzylation and lactam formation. It also shows interesting results when it comes to a pharmacophore study based on ezetimibe as the main ligand in lowering blood cholesterol levels, revealing which substituents on the azetidine-2-one ring are more similar to the ezetimibe skeleton and will more likely bind to NPC1L1 than ezetimibe.

1 July 2014 in Tetrahedron: Asymmetry
Verified
Journal Article
Closed access
CNCarlos T. Nieto
Carlos T. Nieto
MSMateo M. Salgado
Mateo M. Salgado
SDSara H. Domínguez
Sara H. Domínguez
David DiezDavid Diez
David Diez
NGNarciso M. Garrido
Narciso M. Garrido

24 September 2019 in Synlett
Verified
Journal Article
Closed access
PDF file
MSMateo M. Salgado
Mateo M. Salgado
AMAlejandro Manchado
Alejandro Manchado
CNCarlos T. Nieto
Carlos T. Nieto
David DiezDavid Diez
David Diez
NGNarciso M. Garrido
Narciso M. Garrido
A convenient asymmetric synthesis of methyl (2S,3S,6R)-6-(4-fluorophenyl)-2-(4-hydroxyphenyl)-piperidine-3-carboxylate is described, starting from Baylis–Hillman adducts. The route involves a domino process: allylic acetate rearrangement, stereoselective Ireland–Claisen rearrangement and asymmetric Michael addition, which provides a δ-amino acid derivative with full stereochemical control. A subsequent chemoselective transformation of one of the side-chain groups allows an effective cyclization leading to biologically interesting polysubstituted piperidines in which the 2,6-aryl groups could be attached sequentially.

1 September 2018 in Tetrahedron
Verified
Journal Article
Closed access
AMAlejandro Manchado
Alejandro Manchado
MGMercedes García
Mercedes García
MSMateo M. Salgado
Mateo M. Salgado
David DiezDavid Diez
David Diez
NGNarciso M. Garrido
Narciso M. Garrido

5 March 2021 in Molecules
Verified
Journal Article
Open access
PDF file
JTJavier García Tojal
Javier García Tojal
José Vicente Cuevas-VicarioJosé Vicente Cuevas-Vicario
José Vicente Cuevas-Vicario
MRMaría-Josefa Rojo
María-Josefa Rojo
BGBorja Díaz de Greñu
Borja Díaz de Greñu
CHCarla Hernando-Muñoz
Carla Hernando-Muñoz
Tomás TorrobaTomás Torroba
Tomás Torroba
We describe the synthesis of fluorogenic arylureas and amides and their interaction with primary or secondary amines under air and light in organic-aqueous mixtures to give rise to a new class of persistent organic radicals, described on the basis of their electron paramagnetic resonance (EPR), as well as UV–vis, fluorescence, NMR, and quantum mechanics calculations, and their prospective use as multi-signal reporters in a smart label for fish freshness.

1 October 2017 in Tetrahedron: Asymmetry
Verified
Journal Article
Closed access
ARAlfonso G. Rubia
Alfonso G. Rubia
MSMateo M. Salgado
Mateo M. Salgado
CNCarlos T. Nieto
Carlos T. Nieto
AMAlejandro Manchado
Alejandro Manchado
David DiezDavid Diez
David Diez
NGNarciso M. Garrido
Narciso M. Garrido